Thermo, Moderna ink COVID-19 vaccine manufacturing deal

By The Science Advisory Board staff writers

June 2, 2021 -- Moderna has signed a deal with Thermo Fisher Scientific to provide manufacturing services and supply packaging for its COVID-19 vaccine.

Under the agreement, Thermo's manufacturing site in North Carolina will be used for aseptic fill and finish, labeling, and packaging to support the production of hundreds of millions of doses of Moderna's vaccine. Production will start in the third quarter of 2021.

Moderna vaccine 100% effective for teens
Moderna announced its phase II/III study of its COVID-19 vaccine in adolescents has met its primary immunogenicity endpoint with no cases of COVID-19...
Moderna inks South Korean mRNA vaccine collaborations
Moderna has inked two memoranda of understanding agreements with South Korea for messenger RNA (mRNA) vaccine research and manufacturing in that country.
Thermo Fisher to open cell center, debut microscope
Thermo Fisher Scientific has announced it will open a cell therapy center with the University of California, San Francisco. The company has also unveiled...
Thermo Fisher announces Q1 revenue increase
Thermo Fisher Scientific said that its efforts to help scale vaccine production and support diagnostic testing globally during the COVID-19 pandemic were...
Thermo Fisher to sell Progen primary antibodies
Gene therapy tools manufacturer Progen Biotechnik has signed a nonexclusive distribution agreement with Thermo Fisher Scientific.

Copyright © 2021 scienceboard.net


Conferences
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
Online
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter